Figure 4From: A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient settingPercentage of patients and their caregivers rating study medication as better than the previous antipsychotic medication during the 12-week switching period. Subjects with a preference of medication rating of 'much better' or 'slightly better' were included in the total.Back to article page